IL-33 in Atherosclerosis: An Insufficiently Explored and Controversial Research Area

Cardiovasc Drugs Ther. 2024 Jan 31. doi: 10.1007/s10557-024-07553-5. Online ahead of print.
No abstract available

Publication types

  • Letter